AI Verdict
OKTA has stronger fundamentals based on our AI analysis.
OLMA vs OKTA Fundamental Comparison
| Metric | OLMA | OKTA |
|---|---|---|
| Revenue | N/A | $2.9B |
| Net Income | $-162.5M | $235.0M |
| Net Margin | N/A | 8.1% |
| ROE | -33.9% | 3.4% |
| ROA | -30.5% | 2.4% |
| Current Ratio | 9.95x | 1.43x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-1.87 | $1.31 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
OLMA vs OKTA: Frequently Asked Questions
Is OLMA or OKTA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), OKTA has stronger fundamentals. OLMA is rated SELL (75% confidence) while OKTA is rated HOLD (72% confidence). This is not investment advice.
How does OLMA compare to OKTA fundamentally?
Olema Pharmaceuticals, Inc. has ROE of -33.9% vs Okta, Inc.'s 3.4%. Net margins are N/A vs 8.1% respectively.
Which stock pays higher dividends, OLMA or OKTA?
OLMA has a dividend yield of N/A or no dividend while OKTA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in OLMA or OKTA for long term?
For long-term investing, consider that OLMA has SELL rating with 75% confidence, while OKTA has HOLD rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about OLMA vs OKTA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For OLMA vs OKTA, the AI consensus favors OKTA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.